Latest Insider Transactions at Sensei Biotherapeutics, Inc. (SNSE)
This section provides a real-time view of insider transactions for Sensei Biotherapeutics, Inc. (SNSE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sensei Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sensei Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 16
2022
|
James Peyer |
BUY
Open market or private purchase
|
Direct |
2,551
+0.05%
|
$10,204
$4.25 P/Share
|
|
Feb 16
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,551
+0.05%
|
$10,204
$4.25 P/Share
|
|
Feb 15
2022
|
John Celebi PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
53,900
+49.9%
|
-
|
|
Feb 15
2022
|
Erin Colgan CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
21,000
+49.2%
|
-
|
|
Feb 15
2022
|
Robert Hamilton Pierce Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,000
+50.0%
|
-
|
|
Feb 14
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.19%
|
$40,000
$4.18 P/Share
|
|
Feb 14
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
10,000
+0.19%
|
$40,000
$4.18 P/Share
|
|
Feb 11
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
12,500
+0.24%
|
$50,000
$4.4 P/Share
|
|
Feb 11
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
12,500
+0.24%
|
$50,000
$4.4 P/Share
|
|
Feb 10
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
5,000
+0.1%
|
$20,000
$4.58 P/Share
|
|
Feb 10
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.1%
|
$20,000
$4.58 P/Share
|
|
Feb 08
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.19%
|
$40,000
$4.33 P/Share
|
|
Feb 08
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
10,000
+0.19%
|
$40,000
$4.33 P/Share
|
|
Feb 04
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
2,500
+0.05%
|
$10,000
$4.45 P/Share
|
|
Feb 04
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,500
+0.05%
|
$10,000
$4.45 P/Share
|
|
Feb 03
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
17,500
+0.34%
|
$70,000
$4.65 P/Share
|
|
Feb 03
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
17,500
+0.34%
|
$70,000
$4.65 P/Share
|
|
Jan 28
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
8,900
+0.17%
|
$35,600
$4.22 P/Share
|
|
Jan 28
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
8,900
+0.17%
|
$35,600
$4.22 P/Share
|
|
Jan 27
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
6,100
+0.12%
|
$24,400
$4.31 P/Share
|
|
Jan 27
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
6,100
+0.12%
|
$24,400
$4.31 P/Share
|
|
Jan 26
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
29,900
+0.58%
|
$119,600
$4.62 P/Share
|
|
Jan 26
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
29,900
+0.58%
|
$119,600
$4.62 P/Share
|
|
Jan 25
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
20,100
+0.39%
|
$80,400
$4.86 P/Share
|
|
Jan 25
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
20,100
+0.39%
|
$80,400
$4.86 P/Share
|
|
Jan 24
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
22,707
+0.45%
|
$90,828
$4.69 P/Share
|
|
Jan 24
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
22,707
+0.45%
|
$90,828
$4.69 P/Share
|
|
Jan 21
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
24,703
+0.49%
|
$98,812
$4.94 P/Share
|
|
Jan 21
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
24,703
+0.49%
|
$98,812
$4.94 P/Share
|
|
Jan 20
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
20,000
+0.4%
|
$100,000
$5.17 P/Share
|
|
Jan 20
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.4%
|
$100,000
$5.17 P/Share
|
|
Jan 19
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
10,244
+0.2%
|
$40,976
$4.97 P/Share
|
|
Jan 19
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
10,244
+0.2%
|
$40,976
$4.97 P/Share
|
|
Jan 18
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
10,000
+0.2%
|
$50,000
$5.08 P/Share
|
|
Jan 18
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.2%
|
$50,000
$5.08 P/Share
|
|
Jan 14
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
6,219
+0.12%
|
$24,876
$4.99 P/Share
|
|
Jan 14
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
6,219
+0.12%
|
$24,876
$4.99 P/Share
|
|
Jan 13
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
19,953
+0.4%
|
$99,765
$5.13 P/Share
|
|
Jan 13
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
19,953
+0.4%
|
$99,765
$5.13 P/Share
|
|
Jan 12
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
9,202
+0.19%
|
$46,010
$5.22 P/Share
|
|
Jan 12
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
9,202
+0.19%
|
$46,010
$5.22 P/Share
|
|
Jan 11
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
10,845
+0.22%
|
$54,225
$5.18 P/Share
|
|
Jan 11
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
10,845
+0.22%
|
$54,225
$5.18 P/Share
|
|
Jan 10
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
10,000
+0.2%
|
$50,000
$5.28 P/Share
|
|
Jan 10
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.2%
|
$50,000
$5.28 P/Share
|
|
Dec 30
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
1,127
+0.02%
|
$4,508
$4.85 P/Share
|
|
Dec 30
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
1,127
+0.02%
|
$4,508
$4.85 P/Share
|
|
Dec 29
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
69,000
+1.38%
|
$276,000
$4.98 P/Share
|
|
Dec 29
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
69,000
+1.38%
|
$276,000
$4.98 P/Share
|
|
Dec 28
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
11,288
+0.23%
|
$56,440
$5.28 P/Share
|